Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions
Abstract Background One objective of the Belgian Rare Diseases plan is to improve patients’ management using phenotypic tests and, more specifically, the access to those tests by identifying the biochemical analyses used for rare diseases, developing new financing conditions and establishing referen...
Main Authors: | Nathalie M. Vandevelde, Pieter Vermeersch, Katrien M. J. Devreese, Marie-Françoise Vincent, Béatrice Gulbis, François Eyskens, François Boemer, André Gothot, Viviane O. Van Hoof, Carolien Bonroy, Hedwig Stepman, Geert A. Martens, Xavier Bossuyt, Laurence Roosens, Julie Smet, Hilde Laeremans, Ilse Weets, Jean-Marc Minon, Kris Vernelen, Wim Coucke, Advisory Board of the Action 1 of the Belgian National Plan for Rare Diseases |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13023-021-01728-1 |
Similar Items
-
Scaling-Up the Impact of Aflatoxin Research in Africa. The Role of Social Sciences
by: Francois Stepman
Published: (2018-03-01) -
King of Kings – The Thriumph and Tragedy of Emperor Haile Selassie I of Ethiopia
by: François Stepman
Published: (2016-08-01) -
Embracing change within the CGIAR
by: François Stepman
Published: (2009-11-01) -
Dépistage Néonatal de la Drépanocytose: Nouvelles Méthodologies/Newborn Screening for Sickle Cell Disease: New Methodologies
by: BOEMER, François
Published: (2009) -
Neonatal Screening for Sickle Cell Disease in Belgium for More than 20 Years: An Experience for Comprehensive Care Improvement
by: Béatrice Gulbis, et al.
Published: (2018-11-01)